Plain-language explainers and comparisons on eloralintide and the science around it. Every story is built on one of our evidence pages, lists its sources, and says what it cannot show. It is an editorial layer on top of the reference, not a replacement for it.
Phase 1 Eloralintide: What First in Human Research Actually Found
The earliest human eloralintide studies examined safety, exposure and initial signals, not whether the medicine belongs in routine care.
Read more
Macupatide and Eloralintide: What the Registered Combination Trial Actually Shows
A registered Phase 2 study tests macupatide and eloralintide alone and together in type 2 diabetes. Here is what the registry record confirms.
Read more
Inside ENLIGHTEN: The Phase 3 Trials That Will Test Eloralintide’s Next Chapter
ENLIGHTEN is a collection of registered late-stage studies exploring eloralintide in different populations. Here's what the individual trials are designed to investigate.
Read more
Eloralintide Side Effects: What the Clinical Trials Actually Reported
The weight-loss numbers attracted attention. But nausea, fatigue and treatment discontinuations deserve just as much scrutiny. Here's what researchers reported.
Read more
Eloralintide Clinical Trial Results: What the Weight-Loss Headlines Actually Mean
Eloralintide trials have produced attention-grabbing results. We examine the study findings, safety data, and what the numbers really mean.
Read more